Akses terbuka Jurnal SINTA 1
Intraparenchymal Umbilical Cord Mesenchymal Stem Cell Transplantation in Patients with Subacute Ischemic Stroke: A Preliminary Study of Safety and Early Clinical Outcomes
The Indonesian Biomedical Journal · Vol. 18 No. 5 (2026) · hlm. 461–468
- ISSN
- 2085-3297, 2355-9179
- Terbit
- 2026-11-14
- Penerbit
- Secretariat of The Indonesian Biomedical Journal
- Bahasa
- en
Abstrak
BACKGROUND: Intravenous thrombolysis and mechanical thrombectomy are current standard treatments for ischemic stroke, however their narrow therapeutic window limits eligibility for many patients. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) have emerged as a promising regenerative therapy, but their safety and efficacy need to be further elucidated. Interleukin-6 (IL-6) and brain-derived neurotrophic factor (BDNF) may provide biological insights into the inflammatory and neuroregenerative responses following UC-MSC transplantation. This study was conducted to evaluate the safety and preliminary efficacy, including IL-6 and BDNF level, after stereotactic intraparenchymal UC-MSC transplantation.METHODS: Subjects with subacute ischemic stroke received stereotactic intraparenchymal transplantation of 2×10⁷ allogeneic UC-MSCs into the perolesional ischemic area, 13 to 20 days after stroke onset. Safety was assessed by monitoring the adverse events. Early efficacy was evaluated using the National Institutes of Health Stroke Scale (NIHSS), modified Rankin Scale (mRS), Magnetic Resonance Imaging (MRI), and serum biomarkers, including IL-6 and BDNF. Serum IL-6 levels were measured using electrochemiluminescence immunoassay (ECLIA), while BDNF levels were measured using enzyme-linked immunosorbent assay (ELISA).RESULTS: No serious adverse events related to UC-MSCs administration were observed during the three-month follow-up. No serious adverse events related to UC-MSC administration were observed during the three-month follow-up. From baseline to the third month, improved mRS and NIHSS scores were observed (mean Δ: −0.75 and +4.00, respectively), along with reduced IL-6 (mean Δ: −2.76 pg/mL) and increased BDNF (mean Δ: +3.16 ng/mL).CONCLUSION: UC-MSC transplantation was well tolerated, with improvements in NIHSS and mRS and favorable changes in IL-6 and BDNF levels. These findings suggest that direct intraparenchymal UC-MSCs transplantation may be safe, as no severe adverse events were observed in this preliminary study.KEYWORDS: ischemic stroke, umbilical cord-derived mesenchymal stem cells (UC-MSCs), interleukin-6, brain-derived neurotrophic factor
Kata kunci
Jaringan kolaborasi para penulis
40 penulis · 157 tautan kepenulisan bersama · 93 lintas organisasi · menampilkan 40 yang paling banyak terhubung
Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.
- Hasanuddin University
- Padjadjaran University
- PT Prodia StemCell Indonesia (Indonesia)
- Udayana University
- University of Indonesia
- Maranatha Christian University
- IPB University
- Organisasi lain
- Organisasi berbeda
- Organisasi sama
- Afiliasi tidak diketahui
- Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
| Rekan penulis | Organisasi | Artikel bersama |
|---|---|---|
| Anna Meiliana | Padjadjaran University | 89 |
| Nurrani Mustika Dewi | Padjadjaran University | 45 |
| Suryani As’ád | Hasanuddin University | 14 |
| Yani Lina | Hasanuddin University | 6 |
| Gatot Susilo Lawrence | Hasanuddin University | 6 |
| Albertus Budi Sulistya | Padjadjaran University | 6 |
| Geofanny Facicilia | PT Prodia StemCell Indonesia (Indonesia) | 6 |
| Yussy Afriani Dewi | Padjadjaran University | 6 |
| Ilhamjaya Patellongi | Hasanuddin University | 4 |
| Anwar Santoso | Udayana University | 4 |
| Syakib Bakri | Hasanuddin University | 4 |
| Melisa Intan Barliana | Padjadjaran University | 4 |
| Keri Lestari Dandan | Padjadjaran University | 4 |
| Mawar Subangkit | IPB University | 4 |
| Teguh Ranakusuma | University of Indonesia | 3 |
| Irawan Yusuf | Hasanuddin University | 3 |
| Trilis Yulianti | Hasanuddin University | 3 |
| Ida Paulina Sormin | Hasanuddin University | 3 |
| Erizal Sugiono | Hasanuddin University | 3 |
| Bayu Winata Putera | Hasanuddin University | 3 |
| Indriyanti Rafi Sukmawati | Hasanuddin University | 3 |
| Wahyu Widowati | Maranatha Christian University | 2 |
| Yenny Surjawan | Hasanuddin University | 2 |
| Irma Ruslina Defi | Padjadjaran University | 2 |
| Mansyur Arief | Hasanuddin University | 2 |
| Andri Hidayat | Hasanuddin University | 2 |
| Ferry Sandra | Universitas Trisakti | 2 |
| Marsetio Donosepoetro | Universitas Airlangga | 2 |
| Irma Rahayu Latarissa | Padjadjaran University | 2 |
| Rina Triana | Padjadjaran University | 2 |
| Angliana Chouw | PT Prodia StemCell Indonesia (Indonesia) | 2 |
Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.